Page last updated: 2024-10-29

ketamine and Tracheal Neoplasms

ketamine has been researched along with Tracheal Neoplasms in 2 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Tracheal Neoplasms: New abnormal growth of tissue in the TRACHEA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marks, R1
Tanner, L1
Wenleder, B1
Mignone, L1
Villani, L1
Zappi, L1
Paglia, A1
Mereu, C1
Ivaldi, P1
Verna, A1

Other Studies

2 other studies available for ketamine and Tracheal Neoplasms

ArticleYear
Management of a tumor in the distal trachea while maintaining spontaneous ventilation.
    Journal of anesthesia, 2010, Volume: 24, Issue:6

    Topics: Anesthesia, General; Anesthetics, Dissociative; Deep Sedation; Dexmedetomidine; Electrocardiography;

2010
[A ketalar-propofol combination in laser surgery for removal of obstruction from the upper respiratory tract].
    Minerva anestesiologica, 1990, Volume: 56, Issue:9

    Topics: Aged; Airway Obstruction; Anesthesia, General; Bronchial Neoplasms; Female; Humans; Ketamine; Laser

1990